Search

Your search keyword '"Whitney CG"' showing total 322 results

Search Constraints

Start Over You searched for: Author "Whitney CG" Remove constraint Author: "Whitney CG"
322 results on '"Whitney CG"'

Search Results

1. Prioritising health-care strategies to reduce childhood mortality, insights from Child Health and Mortality Prevention Surveillance (CHAMPS): a longitudinal study

2. Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study

3. Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.

4. Case-control vaccine effectiveness studies: Data collection, analysis and reporting results.

6. Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites

7. Setting Research Priorities to Reduce Global Mortality from Childhood Pneumonia by 2015

8. Shifting genetic structure of invasive serotype 19A pneumococci in the United States.

9. Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 years.

10. The International Infections in Pregnancy (IIP) study: variations in the prevalence of bacterial vaginosis and distribution of morphotypes in vaginal smears among pregnant women.

12. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.

13. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults.

14. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community.

17. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.

22. Setting research priorities to reduce global mortality from childhood pneumonia by 2015.

26. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.

31. Long-term impact of 10-valent pneumococcal conjugate vaccine in Kenya: Nasopharyngeal carriage among children in a rural and an urban site six years after introduction.

32. Prevalence, Clinical Severity, and Serotype Distribution of Pneumococcal Pneumonia Among Adults Hospitalized With Community-Acquired Pneumonia in Tennessee and Georgia, 2018-2022.

33. Derivation and Internal Validation of a Novel Risk Assessment Tool to Identify Infants and Young Children at Risk for Post-Discharge Mortality in Dar es Salaam, Tanzania and Monrovia, Liberia.

34. Neurological Symptoms and Cause of Death Among Young Children in Low- and Middle-Income Countries.

35. Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study.

36. Clinicopathological discrepancies in the diagnoses of childhood causes of death in the CHAMPS network: An analysis of antemortem diagnostic inaccuracies.

37. Morbidity and unplanned healthcare encounters after hospital discharge among young children in Dar es Salaam, Tanzania and Monrovia, Liberia.

38. Predictors of severity and prolonged hospital stay of viral acute respiratory infections (ARI) among children under five years in Burkina Faso, 2016-2019.

39. Post-mortem investigation of deaths due to pneumonia in children aged 1-59 months in sub-Saharan Africa and South Asia from 2016 to 2022: an observational study.

40. Burden of child mortality from malaria in high endemic areas: Results from the CHAMPS network using minimally invasive tissue sampling.

41. Identifying neonates at risk for post-discharge mortality in Dar es Salaam, Tanzania, and Monrovia, Liberia: Derivation and internal validation of a novel risk assessment tool.

42. Identifying delays in healthcare seeking and provision: The Three Delays-in-Healthcare and mortality among infants and children aged 1-59 months.

43. Child deaths caused by Klebsiella pneumoniae in sub-Saharan Africa and south Asia: a secondary analysis of Child Health and Mortality Prevention Surveillance (CHAMPS) data.

44. Hepatic Vitamin A Concentrations and Association with Infectious Causes of Child Death.

45. Effectiveness of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children <2 years old: A prospective population-based study in rural Bangladesh.

46. Prevalence of food insecurity amid COVID-19 lockdowns and sociodemographic indicators of household vulnerability in Harar and Kersa, Ethiopia.

47. Knowledge of COVID-19 symptoms, transmission, and prevention: Evidence from health and demographic surveillance in Southern Mozambique.

48. Household hardships and responses to COVID-19 pandemic-related shocks in Eastern Ethiopia.

49. Provider adherence to clinical care recommendations for infants and children who died in seven low- and middle-income countries in the Child Health and Mortality Prevention Surveillance (CHAMPS) network.

50. COVID-19 impact data for the CHAMPS HDSS network: Data from Harar and Kersa, Ethiopia.

Catalog

Books, media, physical & digital resources